Biren Amin
Stock Analyst at Piper Sandler
(2.02)
# 3,409
Out of 4,944 analysts
62
Total ratings
44.23%
Success rate
-8.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Biren Amin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics | Maintains: Neutral | $11 → $15 | $20.40 | -26.47% | 11 | Jul 29, 2025 | |
| BBIO BridgeBio Pharma | Maintains: Overweight | $63 → $68 | $50.38 | +34.97% | 3 | Jul 14, 2025 | |
| ACRS Aclaris Therapeutics | Assumes: Overweight | $6 | $1.70 | +252.94% | 1 | Jul 10, 2025 | |
| CNTX Context Therapeutics | Reiterates: Overweight | $4.5 → $4 | $0.70 | +471.43% | 1 | Jun 26, 2025 | |
| SLDB Solid Biosciences | Maintains: Overweight | $20 → $17 | $6.68 | +154.49% | 2 | May 16, 2025 | |
| ALLO Allogene Therapeutics | Maintains: Overweight | $9 → $7 | $1.04 | +573.08% | 3 | May 14, 2025 | |
| LENZ LENZ Therapeutics | Maintains: Overweight | $38 → $51 | $39.36 | +29.57% | 1 | Apr 14, 2025 | |
| CNTA Centessa Pharmaceuticals | Initiates: Overweight | $38 | $17.14 | +121.70% | 1 | Mar 31, 2025 | |
| MNPR Monopar Therapeutics | Assumes: Overweight | $76 | $33.51 | +126.80% | 1 | Mar 19, 2025 | |
| CMPX Compass Therapeutics | Initiates: Overweight | $12 | $3.10 | +287.10% | 1 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $74 → $71 | $41.27 | +72.04% | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $34 → $4 | $4.46 | -10.31% | 3 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $35 | $9.59 | +264.96% | 1 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $23 → $21 | $10.01 | +109.79% | 3 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $91 → $115 | $70.90 | +62.20% | 2 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $40 → $32 | $26.58 | +20.39% | 2 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $7 → $3 | $4.54 | -33.92% | 1 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $12.50 | +20.00% | 1 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $70 | $1.49 | +4,597.99% | 2 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $0.39 | +12,896.94% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $5.37 | +346.93% | 1 | Oct 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $3.03 | +1,022.11% | 1 | Oct 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $1,050 → $500 | $7.87 | +6,253.24% | 2 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $6.10 | +129.51% | 1 | Jul 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $657 → $691 | $561.55 | +23.05% | 2 | Jun 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $10 | $1.78 | +463.38% | 1 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $101 | $20.74 | +387.10% | 1 | Nov 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $69 | $131.62 | -47.58% | 1 | Oct 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $155 | $395.92 | -60.85% | 5 | Jul 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $136 | $1.81 | +7,413.81% | 4 | Mar 6, 2017 |
Sarepta Therapeutics
Jul 29, 2025
Maintains: Neutral
Price Target: $11 → $15
Current: $20.40
Upside: -26.47%
BridgeBio Pharma
Jul 14, 2025
Maintains: Overweight
Price Target: $63 → $68
Current: $50.38
Upside: +34.97%
Aclaris Therapeutics
Jul 10, 2025
Assumes: Overweight
Price Target: $6
Current: $1.70
Upside: +252.94%
Context Therapeutics
Jun 26, 2025
Reiterates: Overweight
Price Target: $4.5 → $4
Current: $0.70
Upside: +471.43%
Solid Biosciences
May 16, 2025
Maintains: Overweight
Price Target: $20 → $17
Current: $6.68
Upside: +154.49%
Allogene Therapeutics
May 14, 2025
Maintains: Overweight
Price Target: $9 → $7
Current: $1.04
Upside: +573.08%
LENZ Therapeutics
Apr 14, 2025
Maintains: Overweight
Price Target: $38 → $51
Current: $39.36
Upside: +29.57%
Centessa Pharmaceuticals
Mar 31, 2025
Initiates: Overweight
Price Target: $38
Current: $17.14
Upside: +121.70%
Monopar Therapeutics
Mar 19, 2025
Assumes: Overweight
Price Target: $76
Current: $33.51
Upside: +126.80%
Compass Therapeutics
Feb 19, 2025
Initiates: Overweight
Price Target: $12
Current: $3.10
Upside: +287.10%
Feb 6, 2025
Maintains: Overweight
Price Target: $74 → $71
Current: $41.27
Upside: +72.04%
Jan 30, 2025
Downgrades: Neutral
Price Target: $34 → $4
Current: $4.46
Upside: -10.31%
Dec 2, 2024
Initiates: Overweight
Price Target: $35
Current: $9.59
Upside: +264.96%
Nov 14, 2024
Maintains: Overweight
Price Target: $23 → $21
Current: $10.01
Upside: +109.79%
Nov 8, 2024
Maintains: Overweight
Price Target: $91 → $115
Current: $70.90
Upside: +62.20%
Nov 6, 2024
Maintains: Neutral
Price Target: $40 → $32
Current: $26.58
Upside: +20.39%
Jul 19, 2024
Downgrades: Hold
Price Target: $7 → $3
Current: $4.54
Upside: -33.92%
Jun 21, 2024
Maintains: Overweight
Price Target: $15
Current: $12.50
Upside: +20.00%
May 19, 2023
Maintains: Buy
Price Target: $120 → $70
Current: $1.49
Upside: +4,597.99%
Jan 11, 2021
Initiates: Buy
Price Target: $51
Current: $0.39
Upside: +12,896.94%
Oct 30, 2020
Initiates: Buy
Price Target: $24
Current: $5.37
Upside: +346.93%
Oct 19, 2020
Initiates: Buy
Price Target: $34
Current: $3.03
Upside: +1,022.11%
Sep 14, 2020
Downgrades: Hold
Price Target: $1,050 → $500
Current: $7.87
Upside: +6,253.24%
Jul 24, 2020
Initiates: Buy
Price Target: $14
Current: $6.10
Upside: +129.51%
Jun 12, 2020
Maintains: Buy
Price Target: $657 → $691
Current: $561.55
Upside: +23.05%
Jun 1, 2020
Downgrades: Hold
Price Target: $16 → $10
Current: $1.78
Upside: +463.38%
Nov 9, 2017
Initiates: Buy
Price Target: $101
Current: $20.74
Upside: +387.10%
Oct 3, 2017
Maintains: Buy
Price Target: $66 → $69
Current: $131.62
Upside: -47.58%
Jul 11, 2017
Initiates: Buy
Price Target: $155
Current: $395.92
Upside: -60.85%
Mar 6, 2017
Initiates: Buy
Price Target: $136
Current: $1.81
Upside: +7,413.81%